Physician profile
Jacob Lowry
NPI 1568966398
$2,389.99
in general payments reported to CMS, 2019-2025
21 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.38 · 2021: $115 · 2022: $324 · 2023: $727 · 2024: $471 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,053.07 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $548.63 | 2021-2025 | Matrixrib |
| Davol INC. | $141.13 | 2025 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $84.73 | 2022-2024 | |
| Baxter Healthcare | $83.01 | 2022-2023 | Seprafilm, Floseal |
| Kerecis Limited | $80.87 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Solventum Corporation | $55.60 | 2024-2025 | V.A.C. Granufoam, Activ.A.C., Prevena |
| Haemonetics Corporation | $44.52 | 2023 | Teg5000 Hemostasis Analyzer |
| Csl Behring | $41.76 | 2020-2021 | |
| Medline Industries LP | $35.47 | 2022 | |
| Biocomposites INC | $26.38 | 2023 | Stimulan |
| Allergan, INC. | $24.52 | 2022 | |
| Avanos Medical | $22.98 | 2021 | |
| Sanara Medtech INC. | $22.84 | 2025 | Biasurge |
| Btg International INC. | $21.93 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $20.13 | 2024 | Theragenesis Wound Matrix |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Teleflex LLC | $17.30 | 2024 | Quikclot |
| La Jolla Pharmaceutical Company | $16.85 | 2023 | Giapreza |
| Ethicon US, LLC | $16.15 | 2023 | Surgiflo Hemostatic Matrix, Vistaseal, Enseal |
| E.R. Squibb & Sons, L.L.C. | $13.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Lowry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.